[LGND] QoQ Quarter Result on 30-Jun-2016 [#Q2]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
04-Aug-2016
Financial Year
2016
Quarter
30-Jun-2016 [#Q2]
Profit Trend
QoQ- -187.21%
YoY- -124.46%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Revenue 29,267 38,185 21,619 19,521 29,648 21,192 17,701 39.78%
PBT 6,193 7,230 804 -9,644 9,571 5,826 7,284 -10.24%
Tax 1,114 10,355 160 -3,881 3,694 -515 -217,255 -
NP 5,079 -3,125 644 -5,763 6,608 6,341 199,165 -91.31%
Tax Rate -17.99% -143.22% -19.90% - -38.60% 8.84% 2,982.63% -
Total Cost 24,188 41,310 20,975 25,284 23,040 14,851 -181,464 -
Ratio Analysis
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
NP Margin 17.35 -8.18 2.98 -29.52 22.29 29.92 1,125.16 -93.78%
Per Share
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
EPS 0.24 -0.15 0.03 -0.28 0.32 0.32 10.01 -91.66%
EPS Diluted 0.22 -0.15 0.03 -0.28 0.30 0.29 9.28 -91.72%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.